Industry News

SIGNATURE KITCHEN SUITE STUNS WITH ITS PRECISION AND INNOVATION AT MILAN DESIGN WEEK 2022

LG Solidifies its Ultra-Premium Status in the European Market With its High-End Built-In Kitchen Solutions SEOUL, South Korea, June 7, 2022 /PRNewswire/ -- LG Electronics (LG) will present the essence of its ultra-premium built-in kitchen appliance brand at Milan Design Week 2022, the globally-r...

2022-06-07 15:07 3644

AV-Comparatives Releases Factsheet for March-April Enterprise Malware and Real-World Protection Tests

INNSBRUCK, Austria, June 7, 2022 /PRNewswire/ -- AV-Comparatives, the independent ISO-certified security software evaluation lab, has released the latest results from the Business Main-Test Series, which evaluated a range of anti-virus products in business environments. This report is brought in ...

2022-06-07 15:00 10594

Tencent Recognized as a Challenger in 2022 Gartner(R) Magic Quadrant(TM) for Cloud AI Developer Services

HONG KONG, June 7, 2022 /PRNewswire/ -- Gartner Inc., a company that delivers actionable, objective insight to executives and their teams, has released its 2022 Magic Quadrant for Cloud AI Developer Services. Tencent has been recognized in this Magic Quadrant for three consecutive years, formerl...

2022-06-07 14:50 2532

BRV China-backed eVTOL Start-up Zerog Closes Nearly RMB10 Million Seed Round

HONG KONG, June 7, 2022 /PRNewswire/ -- Zerog, a Chinese electric vertical take-off and landing (eVTOL) aircraft developer, recently completed a nearly RMB10 million (USD1.48 million) seed round with BlueRun Ventures China (BRV China) as the sole investor. The financing closes as theNanjing-based ...

2022-06-07 14:50 2394

Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting

KANAGAWA, Japan, June 7, 2022 /PRNewswire/ -- Chordia Therapeutics Inc. ("Chordia"), a biotech company engaged in the research and development of novel therapies for cancers, today announced that it has presented the interim results from the Phase 1 clinical trial of CTX-712, a selective pan-CDC-...

2022-06-07 14:00 2054

Nippon Express (Belgium) Opens Genk Logistics Centre

TOKYO, June 7, 2022 /PRNewswire/ -- Nippon Express (Belgium) N.V./S.A., a group company of Nippon Express Holdings, Inc., has established its fourth business location inBelgium -- the Genk Logistics Centre -- in Genk Green Logistics Park situated in the east of the country, and the Centre opened ...

2022-06-07 14:00 2200

Clean Shipping: Berge Bulk and Kongsberg Maritime join forces to advance marine decarbonisation

* Berge Bulk and Kongsberg Maritime set up a joint development initiative to advance marine decarbonisation technologies. * The goal is to identify and test emerging decarbonisation technologies and advance the integration of emerging and existing technologies into deployable marine solutions...

2022-06-07 14:00 2809

Geekbuying Releases New UI and Branding Strategy on 10th Anniversary

SHENZHEN, China, June 7, 2022 /PRNewswire/ -- Geekbuying, China's leading online retailer focusing on cross-border export e-commerce, announced a brand upgrade inJune 2022, releasing a new logo and VI system, branding position, and core values. It is transforming from an online shopping platfo...

2022-06-07 14:00 4003

Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting

KANAGAWA, Japan, June 7, 2022 /PRNewswire/ -- Chordia Therapeutics Inc. ("Chordia"), a biotech company engaged in the research and development of novel therapies for cancers, today announced that it has presented the interim results from the Phase 1 clinical trial of CTX-712, a selective pan-CDC-...

2022-06-07 14:00 2801

Nippon Express (Belgium) Opens Genk Logistics Centre

TOKYO, June 7, 2022 /PRNewswire/ -- Nippon Express (Belgium) N.V./S.A., a group company of Nippon Express Holdings, Inc., has established its fourth business location inBelgium -- the Genk Logistics Centre -- in Genk Green Logistics Park situated in the east of the country, and the Centre opened ...

2022-06-07 14:00 3282

ALE Device introduces a high-end 5-inch IPS SIP DeskPhone with built-in 2.5/5G Wi-Fi and Bluetooth 5.0

Alcatel-Lucent Enterprise M8 DeskPhone: more than a phone SHANGHAI, June 7, 2022 /PRNewswire/ -- ALE China Co., Ltd, a leader in audio technology for the global landline phone market, trading under the name ofALE Device , is introducing a high-end SIP DeskPhone under i...

2022-06-07 13:13 4660

ManpowerGroup Talent Solutions Named a Star Performer and Global Leader in Recruitment Process Outsourcing by Everest Group

Recognized for Breadth and Depth of Global Service Offerings and Advances in Business Intelligence MILWAUKEE, June 7, 2022 /PRNewswire/ -- ManpowerGroup Talent Solutions (NYSE: MAN) has been named a global leader in Recruitment Process Outsourcing (RPO) for the 12th year in the Everest Group PEA...

2022-06-07 13:01 4125

GARNIER MALAYSIA KICKS OFF GARNIER GREEN BEAUTY INITIATIVE WITH PANTAI REMIS BEACH CLEANUP

KUALA LUMPUR, Malaysia, June 7, 2022 /PRNewswire/ -- Garnier Malaysia recently held its first beach clean-up at Pantai Remis in Kuala Selangor as part of its environmental initiative under its Garnier Green Beauty commitments. In 2022, Garnier Malaysia and the Malaysian Nature Society are collabo...

2022-06-07 12:23 3997

SCG Cell Therapy And A*STAR's IMCB Collaborate To Accelerate Clinical Translation of Immune Cell-based Therapy

* The collaboration agreement works toward accelerating the study of SCG's immunotherapy pipeline and candidates such as CAR-T, TCR-T therapies, antibodies, and vaccines. * SCG will contribute its proprietary technologies to the therapeutic development of immune cell-based therapy candidates....

2022-06-07 12:23 3769

Trip.com Group corporate travel arm Trip.Biz releases China market white paper as it shares global expansion strategy

SHANGHAI, June 7, 2022 /PRNewswire/ -- Trip.com Group's corporate travel arm, Trip.Biz, has released a white paper delving into the trends defining the reviving corporate travel management sector in mainlandChina. The Trip.Biz white paper sum...

2022-06-07 12:17 3482

XCMG Ranks in Top Three in KHL Group's Yellow Table for Second Consecutive Year

Its Aerial Work Platform Also Ranks 5th Position in the Access M20 Manufacturers list XUZHOU, China, June 7, 2022 /PRNewswire/ -- XCMG (SHE:000425) is ranked among the top three original equipment manufacturers (OEMs) in the world for the second consecutive year, according to the Yellow Table pu...

2022-06-07 12:00 5902

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018

– Discovered in-house by the internal R&D Team at Antengene, ATG-018 is an orally-bioavailable, small molecule ataxia telangiectasia and Rad3-associated (ATR) kinase inhibitor that targets the DNA damage response (DDR) pathway. – This Phase I study will evaluate the safety, pharmacology and prelim...

2022-06-07 11:34 3684

ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies

SUZHOU, China, and ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- scentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the updated results from a Pha...

2022-06-07 11:30 2646

CapitaLand Investment acquires 22-storey office tower in Melbourne's CBD

Acquisition marks CLI's fifth investment in Australia within six months SINGAPORE, June 7, 2022 /PRNewswire/ -- CapitaLand Investment Limited (CLI) has acquired a freehold office tower in the Western Core of Melbourne's Central Business District for its flagship regional core-plus fund, Capit...

2022-06-07 11:29 4322

ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3%

SUZHOU, China, and ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the latest results from a Pha...

2022-06-07 11:28 2475